Sign in Subscribe

TNXP Stock Rises on Expanded Medicare Access for Fibromyalgia Drug TONMYA

Tonix secured expanded Medicare coverage for its fibromyalgia drug TONMYA, reaching approximately 9 million additional patients starting January 2027.

TNXP Stock Rises on Expanded Medicare Access for Fibromyalgia Drug TONMYA
"TONMYA (cyclobenzaprine HCl sublingual tablets)." Credit: Tonix Pharmaceuticals
Already have an account? Sign in.